Can Medtronic Buy Its Way to Growth? It Sure Thinks So.
Werte in diesem Artikel
Even before Medtronic (NYSE:MDT) announced its fiscal fourth-quarter 2026 earnings, the company was telling Wall Street it was starting down a new path. That's a good thing, because the old path wasn't making investors happy, noting that the stock has fallen more than 40% from its 2021 high.A big part of Medtronic's growth plan is likely to involve acquisitions, such as the already-completed deal for Cathworks and the pending purchase of SPR Therapeutics. Here's what investors need to know about this medical device giant and its attractive 3.8% yield.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Ausgewählte Hebelprodukte auf Medtronic
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Medtronic
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: MotleyFool
